Cover Image
市場調查報告書

美國、墨西哥、加拿大的腎臟移植市場:數量與預測

Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada

出版商 Renub Research 商品編碼 324757
出版日期 內容資訊 英文 53 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國、墨西哥、加拿大的腎臟移植市場:數量與預測 Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada
出版日期: 2015年02月23日 內容資訊: 英文 53 Pages
簡介

北美,是全球最大的腎臟移植市場之一。2014年,北美所實施的移植總數,超過了2萬件。儘管醫療費高,美國的腎臟移植市場,現在成為10億美元產業。

本報告提供北美 (美國、墨西哥、加拿大) 的腎臟移植市場相關調查分析,以數量、市場、市場佔有率為焦點,提供醫藥品銷售額分析、成長推動因素、課題等有系統的資訊。

第1章 摘要整理

第2章 北美 (美國、墨西哥、加拿大) :腎臟移植的數量與預測

第3章 北美 (美國、墨西哥、加拿大) :腎臟移植市場與預測

第4章 北美 (美國、墨西哥、加拿大) :腎臟移植的數量,市場與醫藥品市場佔有率,預測

  • 北美 (美國、墨西哥、加拿大) :腎臟移植的數量與預測
  • 北美 (美國、墨西哥、加拿大) :腎臟移植市場佔有率與預測
  • 美國、墨西哥、加拿大的腎臟移植中心數

第5章 美國

  • 美國:腎臟移植的數量與預測
  • 美國:腎臟移植市場與預測

第6章 墨西哥

  • 墨西哥:腎臟移植的數量與預測
  • 墨西哥:腎臟移植市場與預測

第7章 加拿大

  • 加拿大:腎臟移植的數量與預測
  • 加拿大:腎臟移植市場與預測

第8章 腎臟移植策略 (免疫抑制劑) 醫藥品銷售額分析

  • CellCept (MycophenolateMofetil)
  • Prograf (Tacrolimus)
  • Rapamune (Sirolimus)
  • Myfortic (Mycophenolic Acid)
  • Neoral/Sandimmune (Cyclosporine)
  • Zortress/Certican (Everolimus)

第9章 促進腎臟移植市場成長的要素

  • 生物腎提供的頻率增加
  • 腎臟移植患者通常比起透析患者長壽

第10章 腎臟移植市場課題

  • 腎臟移植待命期間長

圖表

目錄

SUMMARY

The improvement in technology, surgical techniques and immunosuppressive drugs, Kidney transplantation has became the preferred treatment for chronic kidney disease for many people. A transplant may offer the best chance of returning to a more normal life. Kidney transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end stage kidney disease (ESRD).

North America is one of the biggest kidney transplant market in the world. The overall number of Kidney Transplant done in North America (United States, Mexico and Canada) was more than 20 Thousand in 2014. United States is the leader in kidney transplant market in North America. Canada has the least number of kidney transplant done in comparison to United States and Mexico. Despite its high medical cost today United States Kidney Transplant Market is a Billion US$ industry.

Renub Research study titled “Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada” explores a comprehensive assessment of the fast-evolving, high growth Kidney Transplant Market. This 53 page report with 33 Figures & 1 Table provides the number of kidney transplant, as well as market and market shares of Kidney Transplant Market. The report entails major kidney transplant (Immunosuppressant) drug sales analysis. This report also covers drivers and challenges of North America (United States, Mexico and Canada) market.

All the 3 Countries studied in the report are as follows:

  • 1) United States
  • 2) Canada
  • 3) Mexico

All the 6 Kidney Transplant Immunosuppressant) drugs studied in the report are as follows:

  • 1) CellCept (MycophenolateMofetil)
  • 2) Prograf (Tacrolimus)
  • 3) Rapamune (Sirolimus)
  • 4) Myfortic (Mycophenolic Acid)
  • 5) Neoral / Sandimmune (Cyclosporine)
  • 6) Zortress / Certican (Everolimus)

Table of Contents

1. Executive Summary

2. North America (United States, Mexico & Canada) - Number of Kidney Transplant & Forecast

3. North America (United States, Mexico & Canada) - Kidney Transplant Market & Forecast

4. North America (United States, Mexico & Canada) - Number of Kidney Transplant, Market & Drugs Market Share & Forecast

  • 4.1. North America (United States, Mexico & Canada) - Number of Kidney Transplant Share & Forecast
  • 4.2. North America (United States, Mexico & Canada) - Kidney Transplant Market Share & Forecast
  • 4.3. Number of Kidney Transplant Centers in United States, Canada & Mexico

5. United States

  • 5.1. United States - Number of Kidney Transplant & Forecast
  • 5.2. United States - Kidney Transplant Market & Forecast

6. Mexico

  • 6.1. Mexico - Number of Kidney Transplant & Forecast
  • 6.2. Mexico - Kidney Transplant Market & Forecast

7. Canada

  • 7.1. Canada - Number of Kidney Transplant & Forecast
  • 7.2. Canada - Kidney Transplant Market & Forecast

8. Kidney Transplantation (Immunosuppressant) Drug Sales Analysis

  • 8.1. CellCept (MycophenolateMofetil) Drugs Sales & Forecast
  • 8.2. Prograf (Tacrolimus) Drug Sales & Forecast
  • 8.3. Rapamune (Sirolimus) Drug Sales & Forecast
  • 8.4. Myfortic (Mycophenolic Acid) Drug Sales & Forecast
  • 8.5. Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
  • 8.6. Zortress / Certican (Everolimus) Drug Sales & Forecast

9. Growth Drivers in the Kidney Transplant Market

  • 9.1. Frequency of Living Related Kidney Donation Has Increased
  • 9.2. Patients Who Have Kidney Transplants Usually Live Longer Than Patients Receiving Dialysis

10. Challenges in the Kidney Transplant Market

  • 10.1. Kidney Transplant Waitlist is Long

LIST OF FIGURES

  • Figure 2-1: North America (United States, Mexico & Canada) - Number of Kidney Transplant (Number), 2006 - 2014
  • Figure 2-2: North America (United States, Mexico & Canada) - Forecast for Number of Kidney Transplant (Number), 2015 - 2020
  • Figure 3-1: North America (United States, Mexico & Canada) - Kidney Transplant Market (Million US$), 2006 - 2014
  • Figure 3-2: North America (United States, Mexico & Canada) - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 4-1: North America (United States, Mexico & Canada) - Number of Kidney Transplant Share (Percent), 2006 - 2014
  • Figure 4-2: North America (United States, Mexico & Canada) - Forecast for Number of Kidney Transplant Share (Percent), 2015 - 2020
  • Figure 4-3: North America (United States, Mexico & Canada) - Kidney Transplant Market Share (Percent), 2006 - 2014
  • Figure 4-4: North America (United States, Mexico & Canada) - Kidney Transplant Market Share (Percent), 2015 - 2020
  • Figure 5-1: United States - Number of Kidney Transplant (Number), 2004 - 2014
  • Figure 5-2: United States - Forecast for Number of Kidney Transplant (Number), 2015 - 2020
  • Figure 5-3: United States - Kidney Transplant Market (Million US$), 2004 - 2014
  • Figure 5-4: United States - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 6-1: Mexico - Number of Kidney Transplant (Number), 2006 - 2014
  • Figure 6-2: Mexico - Forecast for number of Kidney Transplant (Number), 2015 - 2020
  • Figure 6-3: Mexico - Kidney Transplant Market (Million US$), 2006 - 2014
  • Figure 6-4: Mexico - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 7-1: Canada - Number of Kidney Transplant (Number), 2004 - 2014
  • Figure 7-2: Canada - Forecast for number of Kidney Transplant (Number), 2015 - 2020
  • Figure 7-3: Canada - Kidney Transplant Market (Million US$), 2004 - 2014
  • Figure 7-4: Canada - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 9-1: Worldwide - CellCept Drug Sales (Million US$), 2005 - 2014
  • Figure 9-2: Worldwide - Forecast for CellCept Drug Sales (Million US$), 2015 - 2020
  • Figure 9-3: Worldwide - Prograf Drug Sales (Million US$), 2004 - 2014
  • Figure 9-4: Worldwide - Forecast for Prograf Drug Sales (Million US$), 2015 - 2020
  • Figure 9-5: Worldwide - Rapamune Drug Sales (Million US$), 2009 - 2014
  • Figure 9-6: Worldwide - Forecast for Rapamune Drug Sales (Million US$), 2015 - 2020
  • Figure 9-7: Worldwide - Myfortic Drug Sales (Million US$), 2008 - 2014
  • Figure 9-8: Worldwide - Forecast for Myfortic Drug Sales (Million US$), 2015 - 2020
  • Figure 9-9: Worldwide - Neoral / Sandimmune Drug Sales (Million US$), 2007 - 2014
  • Figure 9-10: Worldwide - Neoral / Sandimmune Drug Sales (Million US$), 2015 - 2020
  • Figure 9-11: Worldwide - Zortress/Certican Drug Sales (Million US$), 2008 - 2014
  • Figure 9-12: Worldwide - Forecast for Zortress / Certican Drug Sales (Million US$), 2015 - 2020
  • Figure 10-1: United States - Number of Kidney Living Donor (Number), 2000 - 2013

LIST OF TABLES

  • Table 4-1: United States, Mexico & Canada - Kidney Transplant Centers (Number), 2014
Back to Top